Philipp Kiefer1, Sabine Meier1, Thilo Noack1, Michael Andrew Borger2, Joerg Ender3, Alexandro Hoyer1, Friedrich Wilhelm Mohr1, Joerg Seeburger4. 1. Department of Cardiac Surgery, University of Leipzig-Heart Center, Leipzig, Germany. 2. Division of Cardiac Surgery, Columbia University, New York, New York. 3. Department of Anaesthesiology, University of Leipzig-Heart Center, Leipzig, Germany. 4. Department of Cardiac Surgery, University of Leipzig-Heart Center, Leipzig, Germany. Electronic address: seej@medizin.uni-leipzig.de.
Abstract
BACKGROUND: Transapical, beating heart, off-pump implantation of neochordae for repair of mitral valve (MV) prolapse is of increasing interest. The aim of this study was to evaluate long term results for MV repair using the NeoChord system (NeoChord, St. Louis Park, MN). METHODS: Six patients underwent treatment for severe primary mitral regurgitation (MR) with the NeoChord DS1000 system as part of the initial device safety and feasibility Transapical Artificial Chordae Tendinae (TACT) trial at our institution (University of Leipzig-Heart Center, Leipzig, Germany). The primary pathology in all patients was isolated posterior leaflet prolapse of the P2 or P3 segment, or both. RESULTS: Successful repair resulting in no or trace MR was achieved in 5 of 6 patients by implantation of three neochordae under transesophageal echocardiographic guidance and normal left ventricular loading conditions. One patient underwent intraoperative conversion to an open MV replacement as a result of leaflet injury. The early postoperative course was uneventful in all remaining patients. Two patients had to undergo reoperation for recurrent MR at 3 and 16 months postoperatively. The remaining 3 patients were followed up for a period of 5 years. These patients were free of cardiac symptoms, and transthoracic examination showed trace or mild to moderate MR at 1-, 2-, and 5-year follow-up. A trend toward reverse remodeling of the left ventricle with no increase in mitral annular dilatation over 5 years was observed. CONCLUSIONS: In select patients, MV repair using the NeoChord system results in very good long-term results without recurrent prolapse, MR, or annular dilatation.
BACKGROUND: Transapical, beating heart, off-pump implantation of neochordae for repair of mitral valve (MV) prolapse is of increasing interest. The aim of this study was to evaluate long term results for MV repair using the NeoChord system (NeoChord, St. Louis Park, MN). METHODS: Six patients underwent treatment for severe primary mitral regurgitation (MR) with the NeoChord DS1000 system as part of the initial device safety and feasibility Transapical Artificial Chordae Tendinae (TACT) trial at our institution (University of Leipzig-Heart Center, Leipzig, Germany). The primary pathology in all patients was isolated posterior leaflet prolapse of the P2 or P3 segment, or both. RESULTS: Successful repair resulting in no or trace MR was achieved in 5 of 6 patients by implantation of three neochordae under transesophageal echocardiographic guidance and normal left ventricular loading conditions. One patient underwent intraoperative conversion to an open MV replacement as a result of leaflet injury. The early postoperative course was uneventful in all remaining patients. Two patients had to undergo reoperation for recurrent MR at 3 and 16 months postoperatively. The remaining 3 patients were followed up for a period of 5 years. These patients were free of cardiac symptoms, and transthoracic examination showed trace or mild to moderate MR at 1-, 2-, and 5-year follow-up. A trend toward reverse remodeling of the left ventricle with no increase in mitral annular dilatation over 5 years was observed. CONCLUSIONS: In select patients, MV repair using the NeoChord system results in very good long-term results without recurrent prolapse, MR, or annular dilatation.
Authors: Thilo Noack; Philipp Kiefer; Christian Besler; Philipp Lurz; Sergey Leontyev; Mohamed Abdel-Wahab; David Michael Holzhey; Joerg Seeburger Journal: Indian J Thorac Cardiovasc Surg Date: 2019-09-10
Authors: Zurab Machaidze; Margherita Mencattelli; Gustavo Arnal; Karl Price; Fei-Yi Wu; Viktoria Weixler; David W Brown; John E Mayer; Pierre E Dupont Journal: J Thorac Cardiovasc Surg Date: 2019-03-21 Impact factor: 5.209
Authors: Annabel M Imbrie-Moore; Yuanjia Zhu; Matthew H Park; Michael J Paulsen; Hanjay Wang; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2020-11-30 Impact factor: 6.439
Authors: Katarzyna Kurnicka; Krzysztof Wróbel; Olga Zdończyk; Maksymilian Bielecki; Zbigniew Juraszyński; Andrzej Biederman; Piotr Pruszczyk Journal: Postepy Kardiol Interwencyjnej Date: 2019-01-21 Impact factor: 1.426
Authors: Krzysztof Wróbel; Katarzyna Kurnicka; Marcin Zygier; Dariusz Zielinski; Wojciech Dyk; Ryszard Wojdyga; Zbigniew Juraszynski; Piotr Pruszczyk; Andrzej Biederman Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-02-05 Impact factor: 1.195